Innate antiviral immune responses to hepatitis B virus

Viruses

Volumn 2, Issue 7, 2010, Pages 1394-1410

  Ait Goughoulte, Malika ^a,b   Lucifora, Julie ^a,b,d   Zoulim, Fabien ^a,b,c   Durantel, David ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔTEL DIEU   (France)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokines; Hepatitis b virus; Innate immunity; Pathogenesis

Indexed keywords

HEPATITIS B ANTIGEN;

ACUTE HEPATITIS; ADAPTIVE IMMUNITY; CHRONIC HEPATITIS; DELAYED DIAGNOSIS; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; NONHUMAN; REVIEW; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 79952130140     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2071394     Document Type: Review

References (72)

1. Dienstag, J.L. Hepatitis B virus infection. N. Engl. J. Med. 2008, 359, 1486-1500.
2. Lavanchy, D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 2005, 34 (Suppl. 1), S1-3.
3. Bertoletti, A.; Gehring, A.J. The immune response during hepatitis B virus infection. J. Gen. Virol. 2006, 87, 1439-1449.
4. Rehermann, B.; Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5, 215-229.
5. Biron, C.A.; Sen, G.N. Innate responses to viral infections. In Fields Virology; 5th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; Volume 1, pp. 249-278.
6. Gao, B.; Jeong, W.I.; Tian, Z. Liver: An organ with predominant innate immunity. Hepatology 2008, 47, 729-736.
7. Racanelli, V.; Rehermann, B. The liver as an immunological organ. Hepatology 2006, 43, S54-62.
8. Crispe, I.N. The liver as a lymphoid organ. Annu. Rev. Immunol. 2009, 27, 147-163.
9. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801.
10. Kawai, T.; Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 2006, 7, 131-137.
11. Randall, R.E.; Goodbourn, S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89, 1-47.
12. Samuel, C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14, 778-809.
13. Martinon, F.; Mayor, A.; Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27, 229-265.
14. Zarember, K.A.; Godowski, P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168, 554-561.
15. Liu, S.; Gallo, D.J.; Green, A.M.; Williams, D.L.; Gong, X.; Shapiro, R.A.; Gambotto, A.A.; Humphris, E.L.; Vodovotz, Y.; Billiar, T.R. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect. Immun. 2002, 70, 3433-3442.
16. Nishimura, M.; Naito, S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 2005, 20, 452-477.
17. Ojaniemi, M.; Liljeroos, M.; Harju, K.; Sormunen, R.; Vuolteenaho, R.; Hallman, M. TLR-2 is upregulated and mobilized to the hepatocyte plasma membrane in the space of Disse and to the Kupffer cells TLR-4 dependently during acute endotoxemia in mice. Immunol. Lett. 2006, 102, 158-168.
18. Paik, Y.H.; Schwabe, R.F.; Bataller, R.; Russo, M.P.; Jobin, C.; Brenner, D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37, 1043-1055.
19. Hornung, V.; Rothenfusser, S.; Britsch, S.; Krug, A.; Jahrsdorfer, B.; Giese, T.; Endres, S.; Hartmann, G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168, 4531-4537.
20. Vogel, S.N.; Fitzgerald, K.A.; Fenton, M.J. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 2003, 3, 466-477.
21. Iwasaki, A.; Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science, 327, 291-295.
22. Webster, G.J.; Reignat, S.; Maini, M.K.; Whalley, S.A.; Ogg, G.S.; King, A.; Brown, D.; Amlot, P.L.; Williams, R.; Vergani, D.; Dusheiko, G.M.; Bertoletti, A. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000, 32, 1117-1124.
23. Menne, S.; Cote, P.J. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J. Gastroenterol. 2007, 13, 104-124.
24. Wieland, S.F.; Chisari, F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 2005, 79, 9369-9380.
25. Coffin, C.S.; Michalak, T.I. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J. Clin. Invest. 1999, 104, 203-212.
26. Lew, Y.Y.; Michalak, T.I. In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J. Virol. 2001, 75, 1770-1782.
27. Wieland, S.; Thimme, R.; Purcell, R.H.; Chisari, F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 6669-6674.
28. Guidotti, L.G.; Chisari, F.V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 2006, 1, 23-61.
29. Stacey, A.R.; Norris, P.J.; Qin, L.; Haygreen, E.A.; Taylor, E.; Heitman, J.; Lebedeva, M.; DeCamp, A.; Li, D.; Grove, D.; Self, S.G.; Borrow, P. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 2009, 83, 3719-3733.
30. Dunn, C.; Peppa, D.; Khanna, P.; Nebbia, G.; Jones, M.; Brendish, N.; Lascar, R.M.; Brown, D.; Gilson, R.J.; Tedder, R.J.; Dusheiko, G.M.; Jacobs, M.; Klenerman, P.; Maini, M.K. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009, 137, 1289-1300.
31. Tan, A.T.; Koh, S.; Goh, W.; Zhe, H.Y.; Gehring, A.J.; Lim, S.G.; Bertoletti, A. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J. Hepatol., 52, 330-339.
32. Guy, C.S.; Mulrooney-Cousins, P.M.; Churchill, N.D.; Michalak, T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 2008, 82, 8579-8591.
33. McClary, H.; Koch, R.; Chisari, F.V.; Guidotti, L.G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 2000, 74, 2255-2264.
34. Guidotti, L.G.; Morris, A.; Mendez, H.; Koch, R.; Silverman, R.H.; Williams, B.R.; Chisari, F.V. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 2002, 76, 2617-2621.
35. Zhou, J.; Lu, L.; Yuen, M.F.; Lam, T.W.; Chung, C.P.; Lam, C.L.; Zhang, B.; Wang, S.; Chen, Y.; Wu, S.H.; Poon, V.K.; Ng, F.; Chan, C.C.; Jiang, S.; Yuen, K.Y.; Zheng, B.J. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J. Hepatol. 2007, 46, 198-205.
36. Zhou, J.; Smith, D.K.; Lu, L.; Poon, V.K.; Ng, F.; Chen, D.Q.; Huang, J.D.; Yuen, K.Y.; Cao, K.Y.; Zheng, B.J. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J. Viral. Hepat. 2009, 16, 45-52.
37. Gripon, P.; Diot, C.; Theze, N.; Fourel, I.; Loreal, O.; Brechot, C.; Guguen-Guillouzo, C. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 1988, 62, 4136-4143.
38. Gripon, P.; Rumin, S.; Urban, S.; Le Seyec, J.; Glaise, D.; Cannie, I.; Guyomard, C.; Lucas, J.; Trepo, C.; Guguen-Guillouzo, C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15655-15660.
39. Hosel, M.; Quasdorff, M.; Wiegmann, K.; Webb, D.; Zedler, U.; Broxtermann, M.; Tedjokusumo, R.; Esser, K.; Arzberger, S.; Kirschning, C.J.; Langenkamp, A.; Falk, C.; Buning, H.; Rose-John, S.; Protzer, U. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009, 50, 1773-1782.
40. Luedde, T.; Trautwein, C. Intracellular survival pathways in the liver. Liver Int. 2006, 26, 1163-1174.
41. Gealy, C.; Denson, M.; Humphreys, C.; McSharry, B.; Wilkinson, G.; Caswell, R. Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J. Virol. 2005, 79, 472-485.
42. Bertoletti, A.; Ferrari, C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003, 38, 4-13.
43. Apostolou, E.; Thanos, D. Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Cell 2008, 134, 85-96.
44. Mossman, K.L.; Macgregor, P.F.; Rozmus, J.J.; Goryachev, A.B.; Edwards, A.M.; Smiley, J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 2001, 75, 750-758.
45. Christen, V.; Duong, F.; Bernsmeier, C.; Sun, D.; Nassal, M.; Heim, M.H. Inhibition of alpha interferon signaling by hepatitis B virus. J. Virol. 2007, 81, 159-165.
46. Fernandez, M.; Quiroga, J.A.; Carreno, V. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J. Gen. Virol. 2003, 84, 2073-2082.
47. Rosmorduc, O.; Sirma, H.; Soussan, P.; Gordien, E.; Lebon, P.; Horisberger, M.; Brechot, C.; Kremsdorf, D. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J. Gen. Virol. 1999, 80 (Pt 5), 1253-1262.
48. Lucifora, J.; Durantel, D.; Belloni, L.; Barraud, L.; Villet, S.; Vincent, I.E.; Margeridon-Thermet, S.; Hantz, O.; Kay, A.; Levrero, M.; Zoulim, F. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J. Gen. Virol. 2008, 89, 1819-1828.
49. Lucifora, J.; Durantel, D.; Testoni, B.; Hantz, O.; Levrero, M.; Zoulim, F. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 2009.
50. Fisicaro, P.; Valdatta, C.; Boni, C.; Massari, M.; Mori, C.; Zerbini, A.; Orlandini, A.; Sacchelli, L.; Missale, G.; Ferrari, C. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009, 58, 974-982.
51. Twu, J.S.; Lee, C.H.; Lin, P.M.; Schloemer, R.H. Hepatitis B virus suppresses expression of human beta-interferon. Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 252-256.
52. Whitten, T.M.; Quets, A.T.; Schloemer, R.H. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J. Virol. 1991, 65, 4699-4704.
53. Guan, S.H.; Lu, M.; Grunewald, P.; Roggendorf, M.; Gerken, G.; Schlaak, J.F. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J. Gastroenterol. 2007, 13, 228-235.
54. Fernandez, M.; Quiroga, J.A.; Martin, J.; Cotonat, T.; Pardo, M.; Horisberger, M.A.; Carreno, V. Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection. J. Med. Virol. 1997, 51, 332-337.
55. Rosmorduc, O.; Petit, M.A.; Pol, S.; Capel, F.; Bortolotti, F.; Berthelot, P.; Brechot, C.; Kremsdorf, D. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 1995, 22, 10-19.
56. Soussan, P.; Pol, J.; Garreau, F.; Schneider, V.; Pendeven, C.L.; Nalpas, B.; Lacombe, K.; Bonnard, P.; Pol, S.; Kremsdorf, D. Expression of Defective Hepatitis B Virus Particles Derived from Singly Spliced RNA Is Related to Liver Disease. J. Infect. Dis. 2008.
57. Foster, G.R.; Ackrill, A.M.; Goldin, R.D.; Kerr, I.M.; Thomas, H.C.; Stark, G.R. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 2888-2892.
58. Foster, G.R.; Goldin, R.D.; Hay, A.; McGarvey, M.J.; Stark, G.R.; Thomas, H.C. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatology 1993, 17, 757-762.
59. Foster, G.R.; Ackrill, A.M.; Goldin, R.D.; Kerr, I.M.; Thomas, H.C.; Stark, G.R. Corections: expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 3632.
60. Wu, M.; Xu, Y.; Lin, S.; Zhang, X.; Xiang, L.; Yuan, Z. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J. Gen. Virol. 2007, 88, 3260-3269.
61. Duong, F.H.; Filipowicz, M.; Tripodi, M.; La Monica, N.; Heim, M.H. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004, 126, 263-277.
62. Cheng, J.; Imanishi, H.; Morisaki, H.; Liu, W.; Nakamura, H.; Morisaki, T.; Hada, T. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1. J. Hepatol. 2005, 43, 465-471.
63. Barton, G.M. Viral recognition by Toll-like receptors. Semin. Immunol. 2007, 19, 33-40.
64. Visvanathan, K.; Skinner, N.A.; Thompson, A.J.; Riordan, S.M.; Sozzi, V.; Edwards, R.; Rodgers, S.; Kurtovic, J.; Chang, J.; Lewin, S.; Desmond, P.; Locarnini, S. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45, 102-110.
65. Isogawa, M.; Robek, M.D.; Furuichi, Y.; Chisari, F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 2005, 79, 7269-7272.
66. Chen, Z.; Cheng, Y.; Xu, Y.; Liao, J.; Zhang, X.; Hu, Y.; Zhang, Q.; Wang, J.; Zhang, Z.; Shen, F.; Yuan, Z. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin. Immunol. 2008, 128, 400-408.
67. Wu, J.; Meng, Z.; Jiang, M.; Pei, R.; Trippler, M.; Broering, R.; Bucchi, A.; Sowa, J.P.; Dittmer, U.; Yang, D.; Roggendorf, M.; Gerken, G.; Lu, M.; Schlaak, J.F. Hepatitis B virus suppresses tolllike receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009, 49, 1132-1140.
68. Fitzgerald-Bocarsly, P.; Dai, J.; Singh, S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008, 19, 3-19.
69. Xie, Q.; Shen, H.C.; Jia, N.N.; Wang, H.; Lin, L.Y.; An, B.Y.; Gui, H.L.; Guo, S.M.; Cai, W.; Yu, H.; Guo, Q.; Bao, S. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect. 2009.
70. Li, N.; Li, Q.; Qian, Z.; Zhang, Y.; Chen, M.; Shi, G. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. Biochem. Biophys. Res. Commun. 2009, 390, 630-635.
71. Tavakoli, S.; Schwerin, W.; Rohwer, A.; Hoffmann, S.; Weyer, S.; Weth, R.; Meisel, H.; Diepolder, H.; Geissler, M.; Galle, P.R.; Lohr, H.F.; Bocher, W.O. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J. Gen. Virol. 2004, 85, 2829-2836.
72. Wang, F.S.; Xing, L.H.; Liu, M.X.; Zhu, C.L.; Liu, H.G.; Wang, H.F.; Lei, Z.Y. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J. Gastroenterol. 2001, 7, 537-541.